ENDOCYTE INC's ticker is and the CUSIP is 29269A952. A total of 3 filers reported holding ENDOCYTE INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $44,000 | -10.2% | 13,700 | -13.3% | 0.00% | – |
Q1 2016 | $49,000 | -56.6% | 15,800 | -44.2% | 0.00% | – |
Q4 2015 | $113,000 | +59.2% | 28,300 | +81.4% | 0.00% | – |
Q3 2015 | $71,000 | +16.4% | 15,600 | +33.3% | 0.00% | – |
Q2 2015 | $61,000 | -55.1% | 11,700 | -46.1% | 0.00% | – |
Q1 2015 | $136,000 | -60.3% | 21,700 | -60.3% | 0.00% | – |
Q4 2014 | $343,000 | -11.8% | 54,600 | -14.6% | 0.00% | – |
Q3 2014 | $389,000 | -33.0% | 63,900 | -27.6% | 0.00% | -100.0% |
Q2 2014 | $581,000 | -22.3% | 88,200 | +180.9% | 0.00% | 0.0% |
Q1 2014 | $748,000 | +1338.5% | 31,400 | +540.8% | 0.00% | – |
Q4 2013 | $52,000 | – | 4,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 308,600 | $1,876,000 | 0.03% |
SABBY MANAGEMENT, LLC | 863 | $525,000 | 0.02% |
Citadel Advisors | 63,900 | $389,000 | 0.00% |